HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $90 | -82.6% | 13,967 | +205.7% | 0.01% | +125.0% |
| Q4 2022 | $517 | -99.9% | 4,569 | -17.5% | 0.00% | +33.3% |
| Q3 2022 | $352,000 | -82.6% | 5,538 | -76.8% | 0.00% | -82.4% |
| Q2 2022 | $2,025,000 | +11.4% | 23,919 | +52.0% | 0.02% | +30.8% |
| Q1 2022 | $1,817,000 | +47.0% | 15,735 | +10.3% | 0.01% | +44.4% |
| Q4 2021 | $1,236,000 | +98.1% | 14,272 | +166.4% | 0.01% | +125.0% |
| Q3 2021 | $624,000 | -89.3% | 5,358 | -90.5% | 0.00% | -88.6% |
| Q2 2021 | $5,810,000 | -28.4% | 56,283 | -34.4% | 0.04% | -27.1% |
| Q1 2021 | $8,114,000 | +43.5% | 85,752 | +17.9% | 0.05% | +33.3% |
| Q4 2020 | $5,655,000 | +749.1% | 72,760 | +746.3% | 0.04% | +620.0% |
| Q3 2020 | $666,000 | +46.1% | 8,597 | +13.2% | 0.01% | +25.0% |
| Q2 2020 | $456,000 | +93.2% | 7,594 | +7.2% | 0.00% | +100.0% |
| Q1 2020 | $236,000 | -2.1% | 7,086 | +3.0% | 0.00% | 0.0% |
| Q4 2019 | $241,000 | – | 6,881 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |